Quirin Privatbank AG (QB7)
Deutsche Börse Xetra · Germany · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 2.920 |
|---|---|
| 52-week range | 2.840 – 4.080 |
| Return, 1 month / 3 months | −3.3% / −9.9% |
| Return, 1 year / 3 years | −13.3% / −7.3% |
| Trend | Below its 200-day average |
| RSI (14) | 42 |
| Volatility (1 year) | 37.2% |
| Worst drawdown (1 year) | -25.7% |
| Average daily value traded | 0.00M EUR |
| Dividend yield | 4.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Quirin Privatbank is a private bank based in Berlin, Germany, that provides fee-based investment advice and wealth management to private clients. It advises individuals on building and managing investment portfolios and offers digital wealth management through its quirion service, which serves clients who prefer to invest online. The bank also provides corporate finance and capital markets services to companies, including support with stock market listings and capital raising.
On this site Quirin Privatbank AG appears as a stock on the Deutsche Börse Xetra (Germany), code QB7, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Quirin Privatbank AG (QB7) trades on the Deutsche Börse Xetra in Germany. It last closed at EUR 2.920 on 27 October 2026.
Its price-based Market X-Ray is 41 out of 100 (a weak price profile), ranking 477 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 13.3% and over the last three months it fell 9.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Deutsche Börse Xetra
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 36 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -9.2% | ||
| From 52-week high | -28.4% | ||
| Momentum | 35 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -9.9% | ||
| 6-month return | -9.2% | ||
| 12-month return, skipping the last month | -10.4% | ||
| Stability (higher is calmer) | 55 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 37.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.7% | ||
| Liquidity | 11 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M EUR | ||
| Zero-volume days | 3.3% | ||
| Income | 83 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 4.5% | ||
| Years with dividends | 6 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −3.9% |
|---|---|
| 1 month | −3.3% |
| 3 months | −9.9% |
| 6 months | −9.2% |
| 1 year | −13.3% |
| 3 years | −7.3% |
| 5 years | +7.4% |
Signals
| 50-day / 200-day average | 3.051 / 3.214 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.100 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 Jun 2026 | EUR 0.1300 |
| 9 Jun 2025 | EUR 0.1600 |
| 10 Jun 2024 | EUR 0.1100 |
| 12 Jun 2023 | EUR 0.0900 |
| 6 Jun 2022 | EUR 0.1400 |
| 29 Nov 2021 | EUR 0.1100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Deutsche Börse Xetra; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.